Team

Meet the Team

Mike Mosunic

Co-Founder & CEO

Mike is the Co-Founder and CEO of Alder Brooks. He is a seasoned business leader and entrepreneur with a proven track record in commercial leadership, serving as Co-Founder & CEO of Wolf Hill Group (sold to Slone Partners) and Chief Commercial Officer at Pathology, Inc. (sold to LabCorp).

Mike is the Co-Founder and CEO of Alder Brooks. He is a seasoned business leader and entrepreneur with a proven track record in commercial leadership, having co-founded Wolf Hill Group (sold to Slone Partners) and served as Chief Commercial Officer at Pathology, Inc.

Before co-founding Alder Brooks, Mike co-founded Wolf Hill Group, a cybersecurity executive search firm that was acquired by Slone Partners in 2022.

Earlier in his career, Mike was the second employee at Slone Partners, where he played a key role in the firm's growth, holding leadership positions including Chief Operating Officer and President of Cybersecurity. He also held VP of Sales roles at LabCorp and Sonic Healthcare and served as Chief Commercial Officer at Pathology, Inc., backed by ABS Capital (sold to LabCorp).

Mike graduated with honors from Le Moyne College, earned an M.A. in Applied Physiology from Columbia University, and completed his MBA at the Marshall School of Business, University of Southern California.

He enjoys skiing with his family, swimming, and walking his Bernese Mountain Dog in the Colorado mountains.

Read more
Read less

Stephen Skrenta

Advisory Board Member & Co-Founder

Stephen is an Advisory Board Member of Alder Brooks and Co-Founder. Stephen was formerly a Senior Managing Director within Blackstone’s advisory business located in New York and London.

Stephen is an Advisory Board Member of Alder Brooks and Co-Founder.  Stephen was formerly a Senior Managing Director within Blackstone’s advisory business located in New York and London.  While at Blackstone Stephen advised the firm's corporate and sovereign clients on acquisitions, divestitures, private capital raises, and financial restructurings.  Stephen began his career on Wall Street at Donaldson, Lufkin & Jenrette.  In 2015 Stephen founded Acabonac Farms, a regenerative agricultural enterprise that works to better the environment and improve animal and human health.

Stephen is a graduate of The University of Pennsylvania’s Wharton School.

Stephen is married, has three children, enjoys ranching, traveling and playing blackjack.

Read more
Read less

Vicki DiFrancesco

Board Advisor

Ms. Vicki DiFrancesco is an influential leader in the laboratory industry and was formerly responsible for building and executing XiFiN’s corporate business development strategies including acquisitions, joint ventures and strategic partnerships that advance company growth.

Ms. Vicki DiFrancesco is an influential leader in the laboratory industry and was formerly responsible for building and executing XiFiN’s corporate business development strategies including acquisitions, joint ventures and strategic partnerships that advance company growth. She remains a Strategic Advisor for XiFiN after retiring in 2022 and now is also a Board Advisor for Alder Brooks.

Ms DiFrancesco was appointed as the first member of US HealthTek’s Advisory Board in March 2023 and a Non Executive Board Director for SpeeDx in September 2023.

Prior to XIFIN, Vicki served as President and CEO of Pathology Inc., the west coast’s premier women’s health laboratory that was acquired by LabCorp in March 2016. Previously, DiFrancesco was Executive Vice President of Sales and Marketing for Spectrum Laboratory Network where she grew revenues and drove expansion into new markets. She also served as Senior Vice President, Sales and Marketing for Specialty Laboratories Inc., where she oversaw marketing, customer service and was instrumental in sale of company to Ameripath in 2005.

Earlier in her career, Vicki worked as the Vice President of Hospital Sales and Marketing at Quest Diagnostics, Inc..  She has also held executive level positions with American Medical Laboratories, sold to Quest Diagnostics, and Laboratory Corporation of America. Vicki formerly served on the Board of Directors of PWNHealth, LLC, sold to Spectrum Equity.

Read more
Read less

Christopher Mosunic, PhD, RD, MBA

Board Advisor

Chris is a licensed Clinical Psychologist and the Chief Clinical Officer at Calm, playing a key role in shaping the brand’s evidence-based programs and spearheading clinical research.

Chris is a licensed Clinical Psychologist and the Chief Clinical Officer at Calm, playing a key role in shaping the brand’s evidence-based programs and spearheading clinical research. With his wealth of experience as an executive healthcare leader at Yale New Haven Health, Johnson and Johnson, Rivermend Health, Advanced Recovery Systems, Vida Health, and a Board Advisor for Alder Brooks, Chris has demonstrated his expertise in building and leading integrated healthcare services.

Chris is also a seasoned Registered Dietitian, noted for his acumen in launching and growing health-focused organizations. His thought leadership is evident in the numerous scientific publications, clinical  programs, and presentations he’s developed on a variety of topics such as cognitive behavioral therapy (CBT), mental health, integrated care, obesity, eating disorders, and substance use disorders.

Chris received his undergraduate degree in Biology & Psychology from Bucknell University, his MS in Nutritional Biochemistry from Tufts, his PhD in clinical psychology from Vanderbilt, and his MBA from Yale.

Read more
Read less